We’ll be attending the “Nitrosamines Impurities Forum (Americas)” next week. Will you join us?

The CPhI Conferences event takes place August 26th-27th and aims to help the industry better understand the global regulatory and toxicological limits to combat nitrosamine impurities, including looking at the strategies used to identify these impurities at the right stage.

Pavel Pihera from the QUINTA-ANALYTICA team will be on-hand to offer expert advice, explain the science behind the detection methods used in Quinta, or just to say hello throughout the two days as the speeches and Q&A sessions evaluate the key analytical techniques used to identify these impurities, and study how adopting correct methodologies can help to avoid product recalls.

Be sure to swing into the chat zone and connect with Pavel if you’re attending, or visit Quinta.cz to learn more about nitrosamine impurities and how Quinta’s world-class detection techniques can help you navigate the sartan saga!

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.